why are millions of eligible Americans still avoiding colon cancer screening? Simply put, many people find the traditional options — colonoscopy and stool-based tests — unpleasant or inconvenient.

Colonoscopies are performed to visually inspect the walls of the colon for several abnormalities that could be a healthcare ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed” or the "Company”), a molecular genetics diagnostic company specializing in ...

One’s biological age, which measures the body’s physiological state, may help predict who is at risk for developing colon ...

However, combined with other signs like blood in stool, weight loss, or abdominal pain, it warrants further investigation. Colorectal cancer is on the rise in recent decades especially in young or ...

The company’s main revenue source is Cologuard, a non-invasive pre- and colorectal cancer [CRC] screening test that was first ...

Colorectal cancer screening options include at-home stool-sample tests, which are more convenient for patients. Despite these alternatives, colonoscopy remains the most effective method.

The World Health Organization estimates that around 900,000 people each year die of colorectal ... in Clinical Cancer Research 4, researchers tested the assay on plasma samples from 80 patients ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer ... a patient’s stool sample to identify genetic mutations that may lead to a cancer diagnosis.

People mailed a free stool test kit are three times more likely to undergo colon cancer screening About 30% of patients sent a free kit completed their screening within six months By comparison ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid in identifying colorectal cancer in early stages. Through polymerase chain reaction (PCR) technology, ...